Six Months Ended | ||
June 30, | ||
2021 | 2020 | |
Cash flows from operating activities: | ||
Net income attributable to Ebix, Inc. | $37,312 | $48,198 |
Net loss attributable to noncontrolling interest | (1.076) | (489) |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Amortization and depreciation | 7,785 | 6,750 |
(Benefit) provision for deferred taxes | (3,175) | 225 |
Share based compensation | 2,717 | 2,253 |
Benefit for doubtful accounts | (2,815) | (50) |
Amortization of right-of-use assets | 2,507 | 3,257 |
Amortization of capitalized software development costs | 1,647 | 1,670 |
Reduction of acquisition accruals | — | (3,308) |
Changes in assets and liabilities, net of effects from acquisitions: | ||
Accounts receivable | 2,025 | 14,190 |
Receivables from service providers | (8,592) | 12,381 |
Payables to service agents | (1,154) | (7,802) |
Other assets | (10,489) | (1,260) |
Accounts payable and accrued expenses | (9,469) | (8,004) |
Accrued payroll and related benefits | (1,318) | 2,130 |
Contract liabilities | 2,182 | (306) |
Lease liabilities | (264) | (3,008) |
Reserve for potential uncertain income tax return positions | 334 | 206 |
Other liabilities | 3,503 | (8,634) |
Net cash provided by operating activities | 21,660 | 58,399 |
Cash flows from investing activities: | ||
Cash paid for acquisitions, net of cash acquired | — | (5,170) |
Capitalized software development costs | (3,106) | (3,257) |
Maturities (purchases) of unrestricted marketable securities, net | 11,250 | (27,301) |
Capital expenditures | (1,705) | (757) |
Net cash provided by (used in) investing activities | 6,439 | (36,485) |
Cash flows from financing activities: | ||
Proceeds from revolving line of credit, net | — | 1,364 |
Principal payments of term loan obligation | (31,297) | (9,414) |
Proceeds from the exercise of stock options | — | 636 |
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested | (119) | (1,841) |
Dividend payments | (4,642) | (4,605) |
Payments of debt obligations | (149) | (119) |
Payments of working capital facility, net | (6,886) | (19,763) |
Payments of financing lease obligations | (48) | (113) |
Net cash used in financing activities | (43,141) | (33,855) |
Effect of foreign exchange rates on cash | (4,806) | (10,030) |
Net change in cash and cash equivalents, and restricted cash | (19,848) | (21,971) |
Cash and cash equivalents, and restricted cash at the beginning of the period | 120,213 | 111,369 |
Cash and cash equivalents, and restricted cash at the end of the period | $100,365 | $89,398 |
Supplemental disclosures of cash flow information: | ||
Interest paid | $14,065 | $15,434 |
Income taxes paid | $12,073 | $2,096 |
Thank You for contacting us. Someone from the RCS team will be contacting you soon.
You are already subscribed for email alerts.
You may automatically receive Ebix, Inc.’s financial information by email. Please enter your contact details for email notifications below and click "Submit"
Link for this page has been sent to the recipient along with your message.
Thank you for visiting Ebix web site. To send this page link directly to a friend or colleague, complete the form below.
Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement
This website is best viewed in ie9+, Firefox, Google Chrome, Opera and on all latest browsers.